Table of Content

Executive Summary
Scope and Definition

1 Industry Outlook
1.1 Market Trends
1.1.1 Technological Innovations in the Sequencing Technology
1.1.2 Numerous Inorganic Growth Activities in the Market
1.2 COVID-19 Impact on Market
1.3 Regulatory Framework
1.3.1 Legal Requirements and Framework in the U.S.
1.3.2 Legal Requirements and Framework in Europe
1.3.3 Legal Requirements and Framework in Japan
1.4 Supply Chain Analysis
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.1.1 Growing Applications of Whole Genome and Exome Sequencing in Clinical Diagnostics
1.5.1.2 Rising Demand for Personalized Medicine Influencing the Demand for Whole Genome and Exome Sequencing
1.5.1.3 Lowering Costs and Increasing Accessibility of Genome Sequencing
1.5.1.4 Ongoing Whole Genome Sequencing Government Initiatives around the World
1.5.2 Market Restraints
1.5.2.1 Privacy and Ethical Concerns due to Increased Risk of Security Breaches
1.5.3 Market Opportunities
1.5.3.1 Increasing Usage of Sequencing Technology in Emerging Markets

2 Global Whole Genome and Exome Sequencing Market (by Product)
2.1 Overview
2.1.1 Kits
2.1.1.1 Target Enrichment Kits
2.1.1.2 Library Preparation Kits
2.1.1.3 Sequencing Kits
2.1.2 Instruments

3 Global Whole Genome and Exome Sequencing Market (by Workflow)
3.1 Overview
3.1.1 Whole Genome Sequencing (WGS)
3.1.1.1 Sample Extraction/Isolation/Purification
3.1.1.2 Library Preparation
3.1.1.3 Library Quantification
3.1.1.4 Analysis (Bioinformatics)
3.1.2 Whole Exome Sequencing (WES)
3.1.2.1 Sample Extraction/Isolation/Purification
3.1.2.2 Library Preparation
3.1.2.3 Library Quantification
3.1.2.4 Target Enrichment
3.1.2.5 Analysis (Bioinformatics)

4 Global Whole Genome and Exome Sequencing Market (by Application)
4.1 Overview
4.1.1 Whole Genome Sequencing (WGS)
4.1.1.1 Oncology
4.1.1.2 Microbial
4.1.1.3 Non-Invasive Prenatal Testing (NIPT)
4.1.1.4 Others
4.1.2 Whole Exome Sequencing (WES)
4.1.2.1 Oncology
4.1.2.2 Rare Disease
4.1.2.3 Gene Discovery
4.1.2.4 Others

5 Global Whole Genome and Exome Sequencing Market (by End User)
5.1 Overview
5.1.1 Pharmaceutical and Biotechnology Companies
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals and Clinics
5.1.4 Research and Academic Institutes
5.1.5 Others

6 Region
6.1 Regional Summary
6.2 North America
6.2.1 Regional Overview
6.2.2 Driving Factors for Market Growth
6.2.3 Factors Challenging the Market
6.2.3.1 By End User
6.2.4 U.S.
6.2.5 Canada
6.3 Europe
6.3.1 Regional Overview
6.3.2 Driving Factors for Market Growth
6.3.3 Factors Challenging the Market
6.3.3.1 By End User
6.3.4 France
6.3.5 Germany
6.3.6 U.K.
6.3.7 Spain
6.3.8 Italy
6.3.9 Netherlands
6.3.10 Rest-of-Europe
6.4 Asia-Pacific
6.4.1 Regional Overview
6.4.2 Driving Factors for Market Growth
6.4.3 Factors Challenging the Market
6.4.3.1 By End User
6.4.4 China
6.4.5 India
6.4.6 Australia
6.4.7 Japan
6.4.8 Singapore
6.4.9 Rest-of-Asia-Pacific
6.5 Latin America
6.5.1 Regional Overview
6.5.2 Driving Factors for Market Growth
6.5.3 Factors Challenging the Market
6.5.3.1 By End User
6.5.4 Brazil
6.5.5 Mexico
6.5.6 Rest-of-Latin America
6.6 Middle East and Africa
6.6.1 Regional Overview
6.6.2 Driving Factors for Market Growth
6.6.3 Factors Challenging the Market
6.6.3.1 By End User
6.6.4 U.A.E.
6.6.5 South Africa
6.6.6 Rest-of-Middle East and Africa

7 Markets - Competitive Benchmarking & Company Profiles
7.1 Key Strategies and Development
7.2 Company Share Analysis
7.3 Company Profiles
7.3.1 Agilent Technologies, Inc.
7.3.1.1 Overview
7.3.1.2 Top Products/Product Portfolio
7.3.1.3 Top Competitors
7.3.1.4 Key Personnel
7.3.1.5 Analyst View
7.3.2 BGI Group (Beijing Genomics Institute (BGI))
7.3.2.1 Overview
7.3.2.2 Top Products
7.3.2.3 Top Competitors
7.3.2.4 Key Personnel
7.3.2.5 Analyst View
7.3.3 Bio-Rad Laboratories, Inc.
7.3.3.1 Overview
7.3.3.2 Top Products/Product Portfolio
7.3.3.3 Top Competitors
7.3.3.4 Key Personnel
7.3.3.5 Analyst View
7.3.4 Eurofins Scientific SE
7.3.4.1 Overview
7.3.4.2 Top Products
7.3.4.3 Top Competitors
7.3.4.4 Key Personnel
7.3.4.5 Analyst View
7.3.5 F. Hoffmann-La Roche Ltd
7.3.5.1 Overview
7.3.5.2 Top Products
7.3.5.3 Top Competitors
7.3.5.4 Key Personnel
7.3.5.5 Analyst View
7.3.6 Illumina, Inc.
7.3.6.1 Overview
7.3.6.2 Top Products/Product Portfolio
7.3.6.3 Top Competitors
7.3.6.4 Key Personnel
7.3.6.5 Analyst View
7.3.7 Laboratory Corporation of America Holdings
7.3.7.1 Overview
7.3.7.2 Top Products/Product Portfolio
7.3.7.3 Top Competitors
7.3.7.4 Key Personnel
7.3.7.5 Analyst View
7.3.8 Novogene Corporation
7.3.8.1 Overview
7.3.8.2 Top Products/Product Portfolio
7.3.8.3 Top Competitors
7.3.8.4 Key Personnel
7.3.8.5 Analyst View
7.3.9 Oxford Nanopore Technologies plc
7.3.9.1 Overview
7.3.9.2 Top Products
7.3.9.3 Top Competitors
7.3.9.4 Key Personnel
7.3.9.5 Analyst View
7.3.10 Pacific Biosciences of California, Inc.
7.3.10.1 Overview
7.3.10.2 Top Products
7.3.10.3 Top Competitors
7.3.10.4 Key Personnel
7.3.10.5 Analyst View
7.3.11 QIAGEN N.V.
7.3.11.1 Overview
7.3.11.2 Top Products
7.3.11.3 Top Competitors
7.3.11.4 Key Personnel
7.3.11.5 Analyst View
7.3.12 Thermo Fisher Scientific, Inc.
7.3.12.1 Overview
7.3.12.2 Top Products
7.3.12.3 Top Competitors
7.3.12.4 Key Personnel
7.3.12.5 Analyst View
7.3.13 ProPhase Labs, Inc.
7.3.13.1 Overview
7.3.13.2 Top Products
7.3.13.3 Top Competitors
7.3.13.4 Key Personnel
7.3.13.5 Analyst View

8 Research Methodology
8.1 Data Sources
8.1.1 Primary Data Sources
8.1.2 Secondary Data Sources
8.1.3 Data Triangulation
8.2 Market Estimation and Forecast

List of Figures
Figure 1: Global Whole Genome and Exome Sequencing Market (by Region), $Million, 2023, 2026, and 2033
Figure 2: Global Whole Genome and Exome Sequencing Market (by Product), $Million, 2023, 2026, and 2033
Figure 3: Global Whole Genome and Exome Sequencing Market (by End User), $Million, 2023, 2026, and 2033
Figure 4: Key Events to Keep Track of within the Whole Genome and Exome Sequencing Market
Figure 5: Value and Supply Chain Analysis, Global Whole Genome and Exome Sequencing Market
Figure 6: Analysis of Market Navigating Factors, 2023-2033
Figure 7: Key Clinical Applications of Whole Genome and Whole Exome Sequencing
Figure 8: Number of Research Papers Mentioning Personalized Medicine in PubMed, 2010-2023
Figure 9: Decreasing Genome Sequencing Costs
Figure 10: Map of a Few Recent and Ongoing Government-Funded National Genomic-Medicine Initiatives
Figure 11: Examples of Security Breaches in Whole Genome and Exome Sequencing
Figure 12: U.S. Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 13: Canada Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 14: France Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 15: Germany Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 16: U.K. Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 17: Spain Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 18: Italy Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 19: Netherlands Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 20: Rest-of-Europe Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 21: China Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 22: India Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 23: Australia Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 24: Japan Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 25: Singapore Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 26: Rest-of-Asia-Pacific Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 27: Brazil Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 28: Mexico Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 29: Rest-of-Latin America Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 30: U.A.E. Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 31: South Africa Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 32: Rest-of-Middle East and Africa Whole Genome and Exome Sequencing Market, $Million, 2023-2033
Figure 33: Strategic Initiatives, January 2021-April 2024
Figure 34: Share of Strategic Initiatives, January 2021-April 2024
Figure 35: Global Whole Genome and Exome Sequencing Market, Company Revenue Share Analysis, 2023
Figure 36: Data Triangulation
Figure 37: Top-Down and Bottom-Up Approach
Figure 38: Assumptions and Limitations

List of Tables
Table 1: Market Snapshot
Table 2: Opportunities across Regions
Table 3: Recent Technological Innovations
Table 4: Few Major Inorganic Growth Activities in the Whole Genome and Exome Sequencing Market
Table 5: Global Whole Genome and Exome Sequencing Market (by Product), $Million, 2023-2033
Table 6: Global Whole Genome and Exome Sequencing Market (by Kits), $Million, 2023-2033
Table 7: Global Whole Genome Sequencing Market (by Workflow), $Million, 2023-2033
Table 8: Global Whole Exome Sequencing Market (by Workflow), $Million, 2023-2033
Table 9: Global Whole Genome Sequencing Market (by Application), $Million, 2023-2033
Table 10: Global Whole Exome Sequencing Market (by Application), $Million, 2023-2033
Table 11: Global Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
Table 12: Global Whole Genome and Exome Sequencing Market (by Region), $Million, 2023-2033
Table 13: North America Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
Table 14: Europe Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
Table 15: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
Table 16: Latin America Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
Table 17: Middle East and Africa Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033